Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer treatment and diagnosis ...

Having a prostate-specific antigen (PSA) test result above 4.0 ng/mL is considered abnormal and it is worth closer testing, a physician said yesterday, as he suggested individuals with a family ...

New data show bimekizumab is the first approved biologic to achieve superior outcomes in psoriatic arthritis vs an IL-23 inhibitor.

Dr Philip Mease shares his clinical insights for diagnosing and treating fibromyalgia and psoriatic arthritis.

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...

In clinical trials, more than half of all patients treated with deucravacitinib achieved at least 20% improvement in American College of Rheumatology response criteria.

Some riddles appear simple until their answer is revealed. This puzzle uses a mysterious setup that encourages quick guesses. However, the correct solution requires careful reasoning. Once explained, ...

Partners and family members could be the first to notice ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

The Massachusetts Registry of Motor Vehicles (RMV) announced enhancements to its Commercial Learner's Permit (CLP) General ...

Last year, organizers say more than 300 men received on-site PSA screenings, and ten participants completed follow-up care as a result.